Annual ROE
-237.22%
+67.15%+22.06%
December 31, 2023
Summary
- As of February 7, 2025, SLRX annual return on equity is -237.22%, with the most recent change of +67.15% (+22.06%) on December 31, 2023.
- During the last 3 years, SLRX annual ROE has fallen by -204.04% (-614.95%).
- SLRX annual ROE is now -650.46% below its all-time high of -31.61%, reached on December 31, 2015.
Performance
SLRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-140.30%
+8.34%+5.61%
September 30, 2024
Summary
- As of February 7, 2025, SLRX quarterly return on equity is -140.30%, with the most recent change of +8.34% (+5.61%) on September 30, 2024.
- Over the past year, SLRX quarterly ROE has increased by +11.91% (+7.82%).
- SLRX quarterly ROE is now -1107.40% below its all-time high of -11.62%, reached on September 30, 2014.
Performance
SLRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SLRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.1% | +7.8% |
| 3 y3 years | -615.0% | +52.1% |
| 5 y5 years | -107.7% | +52.1% |
SLRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -619.5% | +22.1% | -335.4% | +52.1% |
| 5 y | 5-year | -619.5% | +22.1% | -414.7% | +52.1% |
| alltime | all time | -650.5% | +22.1% | -1107.4% | +52.1% |
Salarius Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -140.30%(-5.6%) |
| Jun 2024 | - | -148.64%(-2.3%) |
| Mar 2024 | - | -152.21%(-23.1%) |
| Dec 2023 | -237.22%(-22.1%) | -197.96%(-16.5%) |
| Sep 2023 | - | -236.94%(-19.1%) |
| Jun 2023 | - | -292.88%(+50.6%) |
| Mar 2023 | - | -194.45%(+40.4%) |
| Dec 2022 | -304.37%(+823.2%) | -138.48%(+41.2%) |
| Sep 2022 | - | -98.10%(+91.4%) |
| Jun 2022 | - | -51.26%(+20.9%) |
| Mar 2022 | - | -42.39%(+31.6%) |
| Dec 2021 | -32.97%(-0.6%) | -32.22%(+11.2%) |
| Sep 2021 | - | -28.97%(+6.3%) |
| Jun 2021 | - | -27.26%(-3.2%) |
| Mar 2021 | - | -28.17%(-32.4%) |
| Dec 2020 | -33.18%(-52.5%) | -41.68%(-15.4%) |
| Sep 2020 | - | -49.27%(-27.9%) |
| Jun 2020 | - | -68.37%(-5.7%) |
| Mar 2020 | - | -72.52%(-18.5%) |
| Dec 2019 | -69.84% | -88.94%(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -89.43%(+8.3%) |
| Jun 2019 | - | -82.57%(-34.8%) |
| Mar 2019 | - | -126.62%(-2.1%) |
| Dec 2018 | -114.21%(+46.6%) | -129.35%(+3.4%) |
| Sep 2018 | - | -125.15%(+4.9%) |
| Jun 2018 | - | -119.36%(+27.7%) |
| Mar 2018 | - | -93.49%(+20.2%) |
| Dec 2017 | -77.88%(+49.4%) | -77.79%(+17.1%) |
| Sep 2017 | - | -66.42%(+10.8%) |
| Jun 2017 | - | -59.97%(+5.7%) |
| Mar 2017 | - | -56.71%(+2.1%) |
| Dec 2016 | -52.13%(+64.9%) | -55.56%(+11.6%) |
| Sep 2016 | - | -49.79%(+17.5%) |
| Jun 2016 | - | -42.39%(+22.8%) |
| Mar 2016 | - | -34.53%(+19.9%) |
| Dec 2015 | -31.61% | -28.79%(+41.3%) |
| Sep 2015 | - | -20.38%(+12.9%) |
| Jun 2015 | - | -18.05%(+29.3%) |
| Mar 2015 | - | -13.96%(+20.1%) |
| Sep 2014 | - | -11.62% |
FAQ
- What is Salarius Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual ROE year-on-year change?
- What is Salarius Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly ROE year-on-year change?
What is Salarius Pharmaceuticals annual return on equity?
The current annual ROE of SLRX is -237.22%
What is the all time high annual ROE for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual return on equity is -31.61%
What is Salarius Pharmaceuticals annual ROE year-on-year change?
Over the past year, SLRX annual return on equity has changed by +67.15% (+22.06%)
What is Salarius Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SLRX is -140.30%
What is the all time high quarterly ROE for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly return on equity is -11.62%
What is Salarius Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SLRX quarterly return on equity has changed by +11.91% (+7.82%)